Impact of heterogeneity and effect size on the estimation of the optimal information size: analysis of recently published meta-analyses

被引:26
作者
Garcia-Alamino, Josep M. [1 ]
Bankhead, Clare [1 ]
Heneghan, Carl [1 ]
Pidduck, Nicola [1 ]
Perera, Rafael [1 ]
机构
[1] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England
关键词
TRIAL SEQUENTIAL-ANALYSIS; METHODOLOGICAL QUALITY; ADJUVANT CHEMOTHERAPY; SYSTEMATIC REVIEWS; COCHRANE; CANCER;
D O I
10.1136/bmjopen-2017-015888
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To estimate the proportion of systematic reviews that meet the optimal information size (OIS) and assess the impact heterogeneity and effect size have on the OIS estimate by type of outcome (eg, mortality, semiobjective or subjective). Methods We carried out searches of Medline and Cochrane to retrieve meta-analyses published in systematic reviews from 2010 to 2012. We estimated the OIS using Trial Sequential Analysis software (TSA V.0.9) and based on several heterogeneity and effect size scenarios, stratifying by type of outcome (mortality/semiobjective/subjective) and by Cochrane/non-Cochrane reviews. Results We included 137 meta-analyses out of 218 (63%) potential systematic reviews (one meta-analysis from each systematic review). Of these reviews, 83 (61%) were Cochrane and 54 (39%) non-Cochrane. The Cochrane reviews included a mean of 6.5 (SD 6.1) studies and the non-Cochrane included a mean of 13.2 (SD 10.2) studies. The mean number of patients was 2619.1 (SD 6245.8 or median 586.0) for the Cochrane and 19 888.5 (SD 32 925.7 or median 6566.5) patients for the non-Cochrane reviews. The percentage of systematic reviews that achieved the OIS for all-cause mortality outcome were 0% Cochrane and 25% for non-Cochrane reviews; for semiobjective outcome 17% for Cochrane and 46% for non-Cochrane reviews and for subjective outcome 45% for Cochrane and 72% for non-Cochrane reviews. Conclusions The number of systematic reviews that meet an optimal information size is low and varies depending on the type of outcome and the type of publication. Less than half of primary outcomes synthesised in systematic reviews achieve the OIS, and therefore the conclusions are subject to substantial uncertainty.
引用
收藏
页数:8
相关论文
共 29 条
[1]   Comparative Effectiveness of Warfarin and New Oral Anticoagulants for the Management of Atrial Fibrillation and Venous Thromboembolism A Systematic Review [J].
Adam, Soheir S. ;
McDuffie, Jennifer R. ;
Ortel, Thomas L. ;
Williams, John W., Jr. .
ANNALS OF INTERNAL MEDICINE, 2012, 157 (11) :796-+
[2]   Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis [J].
Afshari, Arash ;
Wetterslev, Jorn ;
Brok, Jesper ;
Moller, Ann .
BMJ-BRITISH MEDICAL JOURNAL, 2007, 335 (7632) :1248-1251
[3]   Random error in cardiovascular meta-analyses: How common are false positive and false negative results? [J].
AlBalawi, Zaina ;
McAlister, Finlay A. ;
Thorlund, Kristian ;
Wong, Michelle ;
Wetterslev, Jorn .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) :1102-1107
[4]   Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data [J].
Auperin, A. ;
Le Chevalier, T. ;
Le Pechoux, C. ;
Pignon, J. P. ;
Tribodet, H. ;
Burdett, S. ;
Stewart, L. A. ;
Tierney, J. F. ;
Stephens, R. J. ;
Arriagada, R. ;
Higgins, J. P. ;
Johnson, D. H. ;
van Meerbeeck, J. ;
Parmar, M. K. B. ;
Souhami, R. L. ;
Bergman, B. ;
Dautzenberg, B. ;
Douillard, J. Y. ;
Dunant, A. ;
Endo, C. ;
Girling, D. J. ;
Imaizumi, M. ;
Kato, H. ;
Keller, S. M. ;
Kimura, H. ;
Knuuttila, A. ;
Kodama, K. ;
Komaki, R. ;
Kris, M. G. ;
Lad, T. ;
Mineo, T. ;
Park, J. H. ;
Piantadosi, S. ;
Pyrhonen, S. ;
Rosell, R. ;
Scagliotti, G. V. ;
Seymour, L. W. ;
Shepherd, F. A. ;
Spiro, S. G. ;
Strauss, G. M. ;
Sylvester, R. ;
Tada, H. ;
Tanaka, F. ;
Torri, V. ;
Wada, H. ;
Waller, D. ;
Xu, G. C. .
LANCET, 2010, 375 (9722) :1267-1277
[5]   Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials [J].
Bangalore, Sripal ;
Kumar, Sunil ;
Wetterslev, Jorn ;
Messerli, Franz H. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[6]   Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses [J].
Brok, Jesper ;
Thorlund, Kristian ;
Gluud, Christian ;
Wetterslev, Jorn .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2008, 61 (08) :763-769
[7]   An Assessment of the Methodological Quality of Published Network Meta-Analyses: A Systematic Review [J].
Chambers, James D. ;
Naci, Huseyin ;
Wouters, Olivier J. ;
Pyo, Junhee ;
Gunjal, Shalak ;
Kennedy, Ian R. ;
Hoey, Mark G. ;
Winn, Aaron ;
Neumann, Peter J. .
PLOS ONE, 2015, 10 (04)
[8]   New treatments compared to established treatments in randomized trials [J].
Djulbegovic, Benjamin ;
Kumar, Ambuj ;
Glasziou, Paul P. ;
Perera, Rafael ;
Reljic, Tea ;
Dent, Louise ;
Raftery, James ;
Johansen, Marit ;
Di Tanna, Gian Luca ;
Miladinovic, Branko ;
Soares, Heloisa P. ;
Vist, Gunn E. ;
Chalmers, Iain .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (10)
[9]  
Hayden JA, 2011, APPR EST PRES BAS RI
[10]   Sequential methods for random-effects meta-analysis [J].
Higgins, Julian P. T. ;
Whitehead, Anne ;
Simmonds, Mark .
STATISTICS IN MEDICINE, 2011, 30 (09) :903-921